PRESS RELEASE
Jan 24, 2023
Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions
Dec 16, 2022
BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
Dec 14, 2022
BioStem Technologies Announces Partnership with Kill Cliff FC
Nov 15, 2022
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
Nov 15, 2022
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
Oct 26, 2022
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
Oct 10, 2022
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
Sep 13, 2022
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
Sep 08, 2022
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
Aug 22, 2022
BioStem Technologies Reports Second Quarter 2022 Operating and Financial Results